Goodman Noah sold KYMR
July 1, 2026 · Form 4 insider transaction
Goodman Noah sold 3,389 shares of Kymera Therapeutics, Inc. at $114.29 per share, a transaction worth $387.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3,389
Price
$114.29
Total value
$387.3K
InsiderGoodman Noah
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 1, 2026
Filing dateJuly 2, 2026
Shares owned after47,179
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.; This number includes 373 shares acquired under the Registrant's employee stock purchase plan.